Citadel Advisors’s Silo Pharma SILO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104K Buy
16,800
+15,370
+1,075% +$98.3K ﹤0.01% 12668
2026
Q1
$7.71K Buy
+1,430
New +$7.39K ﹤0.01% 12785
2025
Q3
Sell
-1,877
Closed -$17.7K 13968
2025
Q2
$17.7K Buy
1,877
+498
+36% +$5.71K ﹤0.01% 12128
2025
Q1
$24.2K Buy
+1,379
New +$30.9K ﹤0.01% 13006
2024
Q4
Sell
-958
Closed -$15.8K 15302
2024
Q3
$15.8K Buy
+958
New +$20.4K ﹤0.01% 12949

Other funds holding SILO

Citadel Advisors's SILO Position: Q2 2026 in Review

Citadel Advisors increased its Silo Pharma (SILO) stake by 1,075% in Q2 2026, buying an estimated $98.3K and bringing the position to 16,800 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #12668.

Citadel Advisors first reported a position in SILO in Q3 2024 and has held it in 5 quarters since. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

  • Citadel Advisors held 16,800 shares of Silo Pharma worth $104K as of Q2 2026.
  • Citadel Advisors bought 15,370 Silo Pharma shares in Q2 2026, an estimated $98.3K.
  • Silo Pharma made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12668 holding.
  • Citadel Advisors first reported a position in Silo Pharma in Q3 2024 and has held it in 5 quarters since.
  • 9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.